← All trials
NCT05501158
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2021
- Primary completion
- Apr 30, 2024
- Completion date
- Jun 30, 2024
- First posted
- Aug 15, 2022
- Last posted
- Aug 19, 2022
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Nalagenetics Pte LtdLead sponsor
- University of IndonesiaStudy chair
- University of IndonesiaCollaborator
- Nalagenetics Pte LtdStudy chair
- St Josephs Hospital and Medical CenterCollaborator
- Groupe hospitalier St Joseph-PARISOverall official - principal investigator
- Nalagenetics Pte LtdOfficial
- University of IndonesiaOfficial
- Groupe hospitalier St Joseph-PARISOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.